{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:53:39Z","timestamp":1790052819564,"version":"4.0.1"},"reference-count":155,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.kint.2018.10.028","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T02:01:00Z","timestamp":1548900060000},"page":"774-786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Costimulatory blockade molecules and\u00a0B-cell\u2013mediated immune response: current\u00a0knowledge and perspectives"],"prefix":"10.1016","volume":"95","author":[{"given":"Claire","family":"Leibler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Thiolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Elsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"El Karoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Grimbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.10.028_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence: attributing causes of kidney transplant loss","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib2","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib3","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.10.028_bib4","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.10.028_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.12703\/P7-51","article-title":"Recent advances in renal transplantation: antibody-mediated rejection takes center stage","volume":"7","author":"Pouliquen","year":"2015","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.kint.2018.10.028_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ki.2011.317","article-title":"A\u00a0stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection","volume":"81","author":"Thaunat","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.028_bib8","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1073\/pnas.0900563106","article-title":"Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and \u201cantibodyome\u201d measures","volume":"106","author":"Li","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2018.10.028_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","author":"Sicard","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.10.028_bib10","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/01.TP.0000132560.77496.CB","article-title":"Association of Fc gamma receptor IIA polymorphisms with acute renal-allograft rejection","volume":"78","author":"Yuan","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.smim.2011.09.002","article-title":"Chronic alloantibody mediated rejection","volume":"24","author":"Smith","year":"2012","journal-title":"Semin Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-6143.2009.02958.x","article-title":"Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice","volume":"10","author":"Hirohashi","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib13","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure","volume":"9","author":"Hidalgo","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib14","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant: clinical pathologic correlations of de novo DSA","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ki.2013.425","article-title":"Can we prevent donor-specific antibodies from developing after ABO-incompatible kidney transplantation?","volume":"85","author":"Rostaing","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.028_bib16","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1681\/ASN.2015070781","article-title":"Effect of immunosuppressive drugs on humoral allosensitization after kidney transplant","volume":"27","author":"Thaunat","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.10.028_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrneph.2017.24","article-title":"Transplantation: desensitization and survival in kidney transplant recipients","volume":"13","author":"S\u00fcsal","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2018.10.028_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.smim.2011.08.014","article-title":"The state of therapy for removal of alloantibody producing plasma cells in transplantation","volume":"24","author":"Everly","year":"2012","journal-title":"Semin Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/TP.0b013e31825d1587","article-title":"The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review","volume":"94","author":"Roberts","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/TP.0000000000002049","article-title":"The treatment of antibody-mediated rejection in kidney transplantation: an updated systematic review and meta-analysis","volume":"102","author":"Wan","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri3802","article-title":"Memory B cells","volume":"15","author":"Kurosaki","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.immuni.2007.07.009","article-title":"Germinal-center organization and cellular dynamics","volume":"27","author":"Allen","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.10.028_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2010.10.032","article-title":"Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter","volume":"143","author":"Victora","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.kint.2018.10.028_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-065X.2012.01124.x","article-title":"Germinal center selection and the development of memory B and plasma cells","volume":"247","author":"Shlomchik","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2018.10.028_bib25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nri.2016.94","article-title":"T\u00a0follicular helper cells in space-time","volume":"16","author":"Qi","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ni.3054","article-title":"Pathophysiology of T follicular helper cells in humans and mice","volume":"16","author":"Ueno","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular helper T cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T\u00a0follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.10.028_bib29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/ajt.13045","article-title":"Neutralizing BAFF\/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model","volume":"15","author":"Kwun","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/TP.0000000000001588","article-title":"Crosstalk between T and B cells in the germinal center after transplantation","volume":"101","author":"Kwun","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib31","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3389\/fimmu.2017.01615","article-title":"Commentary: belatacept does not inhibit follicular T cell-dependent B-cell differentiation in kidney transplantation","volume":"8","author":"Schroder","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib32","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/TP.0000000000001217","article-title":"T\u00a0follicular helper cells in transplantation","volume":"100","author":"Walters","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.10.028_bib34","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.immuni.2013.08.031","article-title":"Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses","volume":"39","author":"Locci","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.10.028_bib35","doi-asserted-by":"crossref","first-page":"176ra32","DOI":"10.1126\/scitranslmed.3005191","article-title":"Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination","volume":"5","author":"Bentebibel","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.kint.2018.10.028_bib36","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/ajt.14142","article-title":"Renal operational tolerance is associated with a defect of blood Tfh cells that exhibit impaired B cell help","volume":"17","author":"Chenouard","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib37","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.immuni.2011.03.023","article-title":"ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6","volume":"34","author":"Choi","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.10.028_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2496","article-title":"The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood","volume":"14","author":"Sage","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib39","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.immuni.2016.04.012","article-title":"T\u00a0cell cosignaling molecules in transplantation","volume":"44","author":"Ford","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.10.028_bib40","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2016.05.002","article-title":"Coinhibitory pathways in the B7-CD28 ligand-receptor family","volume":"44","author":"Schildberg","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.10.028_bib41","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","article-title":"CD28 costimulation: from mechanism to therapy","volume":"44","author":"Esensten","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.10.028_bib42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev.iy.07.040189.002305","article-title":"Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy","volume":"7","author":"Mueller","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature17947","article-title":"EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells","volume":"533","author":"Li","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.kint.2018.10.028_bib44","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.4049\/jimmunol.179.8.5099","article-title":"Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation","volume":"179","author":"Haynes","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature12058","article-title":"Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility","volume":"496","author":"Xu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.kint.2018.10.028_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ni.1690","article-title":"The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells","volume":"10","author":"Bauquet","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib47","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.4049\/jimmunol.1103246","article-title":"Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation","volume":"188","author":"Kroenke","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature13803","article-title":"T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction","volume":"517","author":"Liu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.kint.2018.10.028_bib49","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.4049\/jimmunol.177.7.4927","article-title":"ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells","volume":"177","author":"Bossaller","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib50","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T\u00a0cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.kint.2018.10.028_bib51","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.aaf0683","article-title":"Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent","volume":"355","author":"Kamphorst","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.kint.2018.10.028_bib52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ni.1877","article-title":"PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells","volume":"11","author":"Good-Jacobson","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.immuni.2018.06.012","article-title":"PD-1 controls follicular T helper cell positioning and function","volume":"49","author":"Shi","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.10.028_bib54","doi-asserted-by":"crossref","first-page":"e03180","DOI":"10.7554\/eLife.03180","article-title":"CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection","volume":"3","author":"Linterman","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.kint.2018.10.028_bib55","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.immuni.2014.12.005","article-title":"The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells","volume":"41","author":"Sage","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.10.028_bib56","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1073\/pnas.1414576112","article-title":"CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement","volume":"112","author":"Wang","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2018.10.028_bib57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20091738","article-title":"IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses","volume":"207","author":"Linterman","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2018.10.028_bib58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.immuni.2018.01.008","article-title":"B\u00a0cell receptor and CD40 signaling are rewired for synergistic induction of the c-Myc transcription factor in germinal center B cells","volume":"48","author":"Luo","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.10.028_bib59","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1084\/jem.20161955","article-title":"Co-stimulatory function in primary germinal center responses: CD40 and B7 are required on distinct antigen-presenting cells","volume":"214","author":"Watanabe","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2018.10.028_bib60","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4049\/jimmunol.170.2.781","article-title":"Differential requirements for expression of CD80\/86 and CD40 on B cells for T-dependent antibody responses in\u00a0vivo","volume":"170","author":"Lumsden","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib61","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.4049\/jimmunol.171.11.5707","article-title":"CD40, but not CD154, expression on B cells is necessary for optimal primary B cell responses","volume":"171","author":"Lee","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib62","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.1400798","article-title":"CD4+ T cells and CD40 participate in selection and homeostasis of peripheral B cells","volume":"193","author":"Schwartz","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib63","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1182\/blood-2006-03-012542","article-title":"CD28-mediated regulation of multiple myeloma cell proliferation and survival","volume":"109","author":"Bahlis","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.10.028_bib64","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.immuni.2006.01.012","article-title":"Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells","volume":"24","author":"Delogu","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2018.10.028_bib65","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.20110040","article-title":"Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells","volume":"208","author":"Rozanski","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2018.10.028_bib66","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.4049\/jimmunol.1402260","article-title":"CD28 promotes plasma cell survival, sustained antibody responses, and BLIMP-1 upregulation through its distal PYAP proline motif","volume":"194","author":"Rozanski","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib67","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.4049\/jimmunol.1102728","article-title":"CD28-B7 interaction modulates short- and long-lived plasma cell function","volume":"189","author":"Njau","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib68","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-6143.2005.00749.x","article-title":"Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties","volume":"5","author":"Larsen","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib69","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/ajt.12350","article-title":"Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig","volume":"13","author":"Chen","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib70","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/ajt.13761","article-title":"Delayed CTLA4-Ig treatment reverses ongoing alloantibody responses and rescues allografts from acute rejection","volume":"16","author":"Young","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/ajt.14400","article-title":"Selective CD28 blockade results in superior inhibition of donor-specific T follicular helper cell and antibody responses relative to CTLA4-Ig","volume":"18","author":"Badell","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib72","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1681\/ASN.2017060679","article-title":"Control of humoral response in renal transplantation by belatacept depends on a direct effect on B cells and impaired T follicular helper-B cell crosstalk","volume":"29","author":"Leibler","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.10.028_bib73","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/eji.201343601","article-title":"Cell-extrinsic CTLA4-mediated regulation of dendritic cell maturation depends on STAT3","volume":"44","author":"Kowalczyk","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib74","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.1074\/jbc.M113.519686","article-title":"Novel regulation of CD80\/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells","volume":"289","author":"Koorella","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2018.10.028_bib75","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2018.10.028_bib76","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1056\/NEJMe1515765","article-title":"The clearer BENEFITS of belatacept","volume":"374","author":"Heher","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2018.10.028_bib77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ajt.12526","article-title":"Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib78","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/j.1600-6143.2012.04032.x","article-title":"CD28-specific immunomodulating antibodies: what can be learned from experimental models?","volume":"12","author":"Poirier","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib79","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ajt.12964","article-title":"FR104, an antagonist anti-CD28 monovalent fab\u2019 antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft","volume":"15","author":"Poirier","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib80","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4049\/jimmunol.1501810","article-title":"Selective CD28 antagonist blunts memory immune responses and promotes long-term control of skin inflammation in nonhuman primates","volume":"196","author":"Poirier","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib81","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1681\/ASN.2015070774","article-title":"Anti-CD28 antibody and belatacept exert differential effects on mechanisms of renal allograft rejection","volume":"27","author":"Ville","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.10.028_bib82","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1172\/JCI118146","article-title":"Collagen-induced arthritis in the BB rat: prevention of disease by treatment with CTLA-4-Ig","volume":"96","author":"Knoerzer","year":"1995","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2018.10.028_bib83","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.7520604","article-title":"Treatment of murine lupus with CTLA4Ig","volume":"265","author":"Finck","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.kint.2018.10.028_bib84","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/eji.1830261008","article-title":"Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2","volume":"26","author":"Webb","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib85","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI5857","article-title":"CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris","volume":"103","author":"Abrams","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2018.10.028_bib86","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrneph.2013.183","article-title":"Targeting co-stimulatory pathways: transplantation and autoimmunity","volume":"10","author":"Ford","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2018.10.028_bib87","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/acr.21838","article-title":"Abatacept and reduced immune response to pandemic 2009 influenza A\/H1N1 vaccination in patients with rheumatoid arthritis","volume":"65","author":"Ribeiro","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.kint.2018.10.028_bib88","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1002\/art.27601","article-title":"The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2018.10.028_bib89","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/art.37940","article-title":"Comparison of alternative primary outcome measures for use in lupus nephritis clinical trials","volume":"65","author":"Wofsy","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2018.10.028_bib90","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.38790","article-title":"Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study","volume":"66","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2018.10.028_bib91","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/art.38260","article-title":"Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study","volume":"66","author":"Furie","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2018.10.028_bib92","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.7679801","article-title":"CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome","volume":"259","author":"Allen","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.kint.2018.10.028_bib93","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/361541a0","article-title":"CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM","volume":"361","author":"DiSanto","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.kint.2018.10.028_bib94","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/361539a0","article-title":"Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM","volume":"361","author":"Korth\u00e4uer","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.kint.2018.10.028_bib95","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/9536","article-title":"Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates","volume":"5","author":"Kirk","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2018.10.028_bib96","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2018.10.028_bib97","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2217\/imt.15.1","article-title":"Novel insights into anti-CD40\/CD154 immunotherapy in transplant tolerance","volume":"7","author":"Pinelli","year":"2015","journal-title":"Immunotherapy"},{"key":"10.1016\/j.kint.2018.10.028_bib98","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/72162","article-title":"Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand","volume":"6","author":"Kawai","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2018.10.028_bib99","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/ajt.12330","article-title":"ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet\u00a0allograft survival in nonhuman primates","volume":"13","author":"Watanabe","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib100","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/ajt.12678","article-title":"Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects","volume":"14","author":"Okimura","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib101","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/ajt.12082","article-title":"A\u00a0phase 1, randomized ascending single-dose study of antagonist anti-human CD40 ASKP1240 in healthy subjects","volume":"13","author":"Goldwater","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib102","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1097\/TP.0000000000001456","article-title":"Costimulation blockade in kidney transplantation: beyond belatacept","volume":"100","author":"Rostaing","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib103","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.kint.2018.10.028_bib104","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/01.TP.0000085010.39567.FB","article-title":"Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet\u00a0allograft survival","volume":"76","author":"Gao","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib105","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/01.tp.0000250757.69384.79","article-title":"Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival","volume":"82","author":"Dudler","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib106","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.4049\/jimmunol.1302617","article-title":"B\u00a0cells in T follicular helper cell development and function: separable roles in delivery of ICOS ligand and antigen","volume":"192","author":"Weinstein","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib107","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/ajt.13100","article-title":"A\u00a0pilot trial targeting the ICOS-ICOS-L pathway in nonhuman primate kidney transplantation","volume":"15","author":"Lo","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib108","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1097\/TXD.0000000000000761","article-title":"Pilot study of delayed ICOS\/ICOS-L blockade with \u03b1CD40 to modulate pathogenic alloimmunity in a primate cardiac allograft model","volume":"4","author":"O\u2019Neill","year":"2018","journal-title":"Transplant Direct"},{"key":"10.1016\/j.kint.2018.10.028_bib109","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/01.TP.0000144054.46946.CF","article-title":"Beneficial effects of costimulatory blockade with anti-inducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse","volume":"78","author":"Nabeyama","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib110","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/01.TP.0000165429.57421.D6","article-title":"Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade","volume":"80","author":"Guillonneau","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib111","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.imlet.2013.07.009","article-title":"Expression of co-stimulatory molecule B7-H4 in patients suffering from rheumatoid arthritis","volume":"154","author":"Chen","year":"2013","journal-title":"Immunol Lett"},{"key":"10.1016\/j.kint.2018.10.028_bib112","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Greenwald","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib113","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.canlet.2008.02.067","article-title":"B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation","volume":"266","author":"Song","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.kint.2018.10.028_bib114","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2567.2009.03111.x","article-title":"Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines","volume":"128","author":"Park","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.kint.2018.10.028_bib115","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3389\/fimmu.2017.01765","article-title":"Immunosuppressive effect of B7-H4 pathway in a murine systemic lupus erythematosus model","volume":"8","author":"Xiao","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib116","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3727\/000000006783981837","article-title":"Suppression of human T-cell responses to \u03b2-cells by activation of B7-H4 pathway","volume":"15","author":"Ou","year":"2006","journal-title":"Cell Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib117","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/TP.0b013e318195e5fa","article-title":"Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival","volume":"87","author":"Wang","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib118","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/TP.0b013e318277229d","article-title":"Endogenous expression of B7-H4 improves long-term murine islet\u00a0allograft survival","volume":"95","author":"Wang","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib119","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1600-6143.2010.03250.x","article-title":"In\u00a0vivo function of immune inhibitory molecule B7-H4 in alloimmune responses","volume":"10","author":"Yamaura","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib120","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/ni1174","article-title":"Immune activation modulates hematopoiesis through interactions between CD27 and CD70","volume":"6","author":"Nolte","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib121","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood.V97.9.2708","article-title":"Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators","volume":"97","author":"Kouro","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.10.028_bib122","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-immunol-041015-055531","article-title":"Memory B cells of mice and humans","volume":"35","author":"Weisel","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib123","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood-2002-10-3161","article-title":"Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation","volume":"102","author":"Tarte","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.10.028_bib124","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.4049\/jimmunol.173.6.3901","article-title":"Signaling through CD70 regulates B cell activation and IgG production","volume":"173","author":"Arens","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib125","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.4049\/jimmunol.159.6.2652","article-title":"CD154\/CD40 and CD70\/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling","volume":"159","author":"Jacquot","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib126","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1111\/ajt.12936","article-title":"Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates: CTLA4Ig for induction of mixed chimerism","volume":"14","author":"Yamada","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib127","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1681\/ASN.2010111160","article-title":"Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation","volume":"22","author":"Sharif","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.10.028_bib128","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.trim.2011.02.002","article-title":"Blockade of CD27\/CD70 pathway to reduce the generation of memory T cells and markedly prolong the survival of heart allografts in presensitized mice","volume":"24","author":"Dai","year":"2011","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib129","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/tri.12751","article-title":"Dynamic changes of B-cell compartments in kidney transplantation: lack of transitional B cells is associated with allograft rejection","volume":"29","author":"Svachova","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.kint.2018.10.028_bib130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib131","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ki.2011.502","article-title":"Proteasome inhibitor-based therapy for antibody-mediated rejection","volume":"81","author":"Walsh","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.028_bib132","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ajt.13050","article-title":"Prospective iterative trial of proteasome inhibitor-based desensitization","volume":"15","author":"Woodle","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2018.10.028_bib133","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/TP.0b013e3181dde912","article-title":"Clonal deletion with bortezomib followed by low or no maintenance immunosuppression in renal allograft recipients","volume":"90","author":"Trivedi","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib134","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/TP.0b013e31823f7eea","article-title":"Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients","volume":"93","author":"Morrow","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1681\/ASN.2017070818","article-title":"A\u00a0randomized trial of bortezomib in late antibody-mediated kidney transplant rejection","volume":"29","author":"Eskandary","year":"2018","journal-title":"J\u00a0Am Soc. Nephrol"},{"key":"10.1016\/j.kint.2018.10.028_bib136","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/imr.12389","article-title":"Monoclonal antibodies targeting CD38 in hematological malignancies and beyond","volume":"270","author":"van de Donk","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2018.10.028_bib137","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(15)01120-4","article-title":"Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial","volume":"387","author":"Lonial","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2018.10.028_bib138","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jaci.2016.12.955","article-title":"Could daratumumab be used to treat severe allergy?","volume":"139","author":"Blankestijn","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib139","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fimmu.2017.00306","article-title":"IL-21 receptor antagonist inhibits differentiation of B cells toward plasmablasts upon alloantigen stimulation","volume":"8","author":"de Leur","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib140","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.2337\/db11-0880","article-title":"IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response","volume":"60","author":"Petrelli","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.kint.2018.10.028_bib141","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib142","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"Schneider","year":"1999","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2018.10.028_bib143","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1126\/science.285.5425.260","article-title":"BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator","volume":"285","author":"Moore","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.kint.2018.10.028_bib144","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jmb.2004.08.040","article-title":"The crystal structure of a proliferation-inducing ligand, APRIL","volume":"343","author":"Wallweber","year":"2004","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.kint.2018.10.028_bib145","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1126\/science.1061965","article-title":"BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF","volume":"293","author":"Thompson","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.kint.2018.10.028_bib146","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1313.004","article-title":"BAFF overexpression is associated with autoantibody production in autoimmune diseases","volume":"1050","author":"Pers","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.kint.2018.10.028_bib147","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1517\/14728222.2014.888415","article-title":"Therapeutic targeting of the BAFF\/APRIL axis in systemic lupus erythematosus","volume":"18","author":"Stohl","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.kint.2018.10.028_bib148","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2018.10.028_bib149","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/TP.0000000000001452","article-title":"Interleukin-6, a cytokine critical to mediation of inflammation, autoimmunity and allograft rejection: therapeutic implications of IL-6 receptor blockade","volume":"101","author":"Jordan","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib150","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1126\/science.1257861","article-title":"Dynamic signaling by T follicular helper cells during germinal center B cell selection","volume":"345","author":"Shulman","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.kint.2018.10.028_bib151","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(13)60250-0","article-title":"Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial","volume":"381","author":"Gabay","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2018.10.028_bib152","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1172\/JCI57158","article-title":"Therapeutic strategies for the clinical blockade of IL-6\/gp130 signaling","volume":"121","author":"Jones","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2018.10.028_bib153","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1097\/TP.0000000000000741","article-title":"A\u00a0phase I\/II trial of the interleukin-6 receptor-specific humanized monoclonal (tocilizumab)\u00a0+ intravenous immunoglobulin in difficult to desensitize patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.028_bib154","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1681\/ASN.2008070778","article-title":"IL-6 and TNF-alpha synergistically inhibit allograft acceptance","volume":"20","author":"Shen","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.10.028_bib155","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1600-6143.2011.03770.x","article-title":"Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance","volume":"12","author":"Zhao","year":"2012","journal-title":"Am J Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818308329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818308329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:53:05Z","timestamp":1758761585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818308329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":155,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0085253818308329"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.10.028","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Costimulatory blockade molecules and\u00a0B-cell\u2013mediated immune response: current\u00a0knowledge and perspectives","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}